Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biolife Solutions (NQ: BLFS )

24.07 +0.67 (+2.86%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biolife Solutions

< Previous 1 2 3 Next >
Key Takeaways From BioLife Solns Analyst Ratings
Via Benzinga
BLFS Stock Earnings: BioLife Solns Beats EPS, Beats Revenue for Q2 2024
BLFS stock results show that BioLife Solns beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
BLFS Stock Earnings: BioLife Solns Beats EPS, Beats Revenue for Q1 2024
BLFS stock results show that BioLife Solns beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Meta Platforms, Pure Storage And 2 Other Stocks Insiders Are Selling
Via Benzinga
Recap: BioLife Solns Q4 Earnings
Via Benzinga
Earnings Scheduled For February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. 
Via Benzinga
Earnings Preview For BioLife Solns
Via Benzinga
BioLife Solns: Q3 Earnings Insights
Via Benzinga
BioLife Solns: Q1 Earnings Insights
Via Benzinga
BioLife Solutions's Earnings Outlook
Via Benzinga
BioLife Solutions's Return On Capital Employed Insights
Via Benzinga
BioLife Solns: Q2 Earnings Insights
  BioLife Solns (NASDAQ:BLFS) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Over $1M Bet On Carnival? Check Out These 3 Stocks Insiders Are Buying
Although U.S. stocks closed mixed on Monday, there were a few notable insider trades. 
Via Benzinga
Top 5 Health Care Stocks That Could Blast Off This Month
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Why Shares of BioLife Solutions Plummeted This Week
The company saw revenue decline, year over year, in the second quarter. 
Via The Motley Fool
Why Shares of BioLife Solutions Are Slumping on Wednesday
The company reported declining revenue and reduced annual guidance. 
Via The Motley Fool
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's Session
Gainers Tango Therapeutics, Inc. (NASDAQ: TNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesday. Tango Therapeutics recently posted a narrower quarterly loss. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 11, 2023
Via Benzinga
Earnings Outlook For BioLife Solutions
BioLife Solutions (NASDAQ:BLFS) is set to give its latest quarterly earnings report on Wednesday, 2022-11-09. Here's what investors need to know before the announcement. Analysts estimate that BioLife... 
Via Benzinga
Billionaire Israel Englander Is Betting Big on These 5 Stocks
Millennium Management's Israel Englander is in focus after the billionaire's fund purchased several stocks this month. 
Via InvestorPlace
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Why Magnite Shares Are Trading Higher By Over 45%? Here Are 69 Stocks Moving In Thursday's Mid-Day Session
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares climbed 172% to $0.2769 after dipping 40% on Wednesday. Fast Radius received Bankruptcy court approval of first day motions related to the company's... 
Via Benzinga
34 Stocks Moving In Monday's Mid-Day Session
Gainers Nkarta, Inc. (NASDAQ: NKTX) shares jumped 108.6% to $16.21 after the company announced Phase 1 data from independent dose finding studies of its two lead chimeric antigen... 
Via Benzinga
Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
Gainers 
Via Benzinga
60 Biggest Movers From Yesterday
Gainers Nkarta, Inc. (NASDAQ: NKTX) shares climbed 140.9% to close at $18.72 on Monday after the company announced Phase 1 data from independent dose finding studies of its two... 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.